Browse the evidence

High anabolic responders to resistance training exhibit greater baseline mitochondrial volume (citrate synthase activity) than low responders, suggesting mitochondrial capacity may facilitate muscle hypertrophy.

If you are struggling to build muscle despite consistent training, your mitochondrial capacity might be a limiting factor. While resistance training doesn't always increase mitochondria, high 'responders' tend to have higher baseline levels. Focus on general cardiovascular health alongside lifting to support the energy demands of muscle growth.

Low anabolic responders to resistance training upregulate myofibrillar myozenin-1 (MYOZ1) protein levels, whereas high responders do not, suggesting MYOZ1 may serve as a biomarker for differential adaptation.

This finding is primarily for researchers. For trainees, it suggests that 'low responders' might be using different molecular pathways (like MYOZ1) to adapt compared to 'high responders'. There is no direct training intervention based on this yet.

Acute resistance training enhances or maintains cognitive performance (specifically visuospatial processing) in healthy older adults, regardless of exercise intensity.

For older adults, engaging in a single session of resistance training (whether heavy or light) can boost visuospatial processing skills without causing mental fatigue. You do not need to avoid weights due to fear of 'brain drain'; starting with lighter weights is just as effective for cognitive benefits as heavier weights.

Deliberately faster eccentric phases during squats and bench presses enhance concentric performance (peak velocity) at submaximal loads (60% 1RM), but may not benefit those who already use fast eccentrics.

If you are a trained lifter, try using a faster lowering phase (eccentric) during your squats and bench presses at lighter loads (60% 1RM). This can help you move the bar faster during the lifting phase. However, if you already train with fast eccentrics, switching to slow ones won't give you extra benefits.

Psychological stress significantly reduces force production in competitive powerlifters, particularly women, but does not impair strength in untrained individuals.

If you are a competitive powerlifter, especially if you are a woman, managing psychological stress is crucial for your performance. Each point of increased stress can cost you several kilograms in your lift. Prioritize stress management techniques alongside your physical training.

Eliminating in vivo digestibility requirements (PDCAAS) for protein content claims and relying solely on protein amount per serving aligns food labeling with dietary guidelines, promotes plant-based food consumption, and improves public health outcomes.

If you are eating enough total protein from varied sources, you do not need to worry about complex protein quality scores on labels. Focus on choosing plant-based protein sources (beans, lentils, soy) which are often disadvantaged by current labeling rules. This change helps you make healthier choices that lower saturated fat and increase fiber, supporting long-term health without needing to track complex metrics.

Stricter parental control of eating during childhood (childhood intake control) is inversely associated with adult BMI in French populations.

If you grew up with strict rules about food, you might now rebel against diet advice. This study suggests that in some cultures, early structure actually helps maintain a healthier weight. If you struggle with weight, consider that your current resistance to 'rules' might be a reaction to past strictness. Try to reframe healthy eating as your own choice and power, not a restriction.

In the US, higher perceived external eating pressures (overt pressures to eat) are positively associated with higher BMI.

If you live in the US, social pressure to eat (e.g., at work or family gatherings) may contribute to weight gain. This study links higher perceived pressure to eat with higher BMI. To manage weight, practice polite but firm refusal of food offerings. Recognize that saying 'no' to food is not rude; it is a necessary boundary for your health.

Higher overall hunger levels are associated with healthier meal timing habits, specifically achieving longer overnight fasts (≥ 13 hours) and eating less frequently late at night, contradicting the assumption that hunger prevents adherence to healthy meal timing.

If you are struggling to stick to a meal timing plan (like skipping breakfast or eating early dinner), don't assume hunger is your enemy. This research suggests that people who feel hungrier are actually more likely to achieve longer overnight fasts. Instead of eating to suppress hunger, view hunger as a sign that your body is adapting to the fasting window. Focus on consistency rather than comfort, as hunger may not be the barrier to adherence you think it is.

Higher body mass index (BMI) is associated with lower self-reported physical functioning and overall health-related quality of life (HRQoL) in people with overweight or obesity.

If you have overweight or obesity, your daily physical ability and general health perception are likely lower than average, and this tends to get worse as your BMI increases. This is a measurable health burden, not just a cosmetic issue, and addressing weight may improve your physical functioning.

The presence of cardiovascular (CV) or metabolic comorbidities significantly reduces health-related quality of life (HRQoL) and work productivity in people with overweight or obesity, often more so than BMI alone.

Having overweight or obesity is only part of the story. If you also have heart or metabolic conditions (like diabetes), your quality of life and work productivity are likely significantly lower than someone with the same BMI but no comorbidities. Treating these specific conditions is crucial for your well-being.

People with overweight or obesity and metabolic comorbidities experience significantly higher work impairment (activity impairment and presenteeism) compared to those without such comorbidities.

If you have overweight or obesity and metabolic conditions like diabetes, your work productivity is likely significantly lower than someone with the same BMI but no metabolic issues. This is due to reduced activity levels and effectiveness at work, which are key targets for treatment.

Current interventions, including calorie restriction, physical activity, and pharmacological treatment, show promise in combating obesity, but long-term efficacy and safety need further establishment.

There is no single magic bullet for obesity. The most promising approach combines lifestyle changes (diet and exercise) with medical treatments if necessary. However, long-term success is not guaranteed, and ongoing management is likely required.

Tirzepatide, a dual GLP-1/GIP agonist, may enhance metabolic efficiency and endurance performance by optimizing fat oxidation, delaying glycogen depletion, and improving mitochondrial function.

If you are an endurance athlete using tirzepatide, you may experience improved metabolic efficiency. The drug can help spare glycogen stores and enhance mitochondrial function, potentially supporting longer exercise durations. However, monitor for signs of hypoglycemia during high-intensity training and ensure adequate carbohydrate intake to counteract potential energy deficits.

Tirzepatide is a broadly acceptable and preferred long-term treatment for comorbid obesity and obstructive sleep apnea (COBOSA) by patients, offering efficacy comparable to CPAP with different adherence profiles.

If you have obesity and sleep apnea, tirzepatide is a valid, once-weekly treatment option that many patients prefer over CPAP. Discuss with your doctor if it's right for you, considering factors like cost, side effects, and your preference for injections vs. devices.

Reallocating 30 minutes of daily sedentary time to moderate-to-vigorous physical activity (MVPA) in young, healthy, active adults increases daily energy intake by approximately 113–120 kcal and alters appetite hormones (higher fasting ghrelin, lower postprandial PYY) to compensate for energy expenditure, without affecting hedonic food reward traits.

If you are already active and healthy, increasing your moderate-to-vigorous exercise by 30 minutes a day will likely make you hungrier and cause you to eat about 120 more calories. This is your body's natural way of balancing energy. To manage weight, you must consciously account for this increased intake rather than assuming exercise alone creates a deficit. If your goal is performance, use this hunger to fuel your activity.

Referral to a specialized weight management clinic alongside incretin-based therapy does not significantly improve early glycemic (A1c) or lipid (LDL) outcomes compared to standard diabetes care alone, but increases weight loss only when patients attend 4 or more visits.

If you are starting a GLP-1 or similar medication, standard diabetes care provides similar early blood sugar and cholesterol benefits as specialized weight management clinics. However, to maximize weight loss, you likely need to attend 4 or more specialized weight management visits. Simply getting the prescription and seeing the specialist once may result in less weight loss than standard care alone.

Second-generation incretin-based therapies (semaglutide, tirzepatide) increase the risk of micronutrient deficiencies and related complications, primarily through reduced dietary intake and altered food selection, with real-world data showing a 22.4% incidence of recorded nutritional deficiencies at 12 months.

If you are taking semaglutide or tirzepatide, your reduced food intake may lead to micronutrient gaps. Prioritize nutrient-dense foods (vegetables, lean proteins, dairy) and consider discussing baseline testing (Vitamin D, B12, Iron) with your doctor, especially if you experience GI side effects or rapid weight loss.

Incretin-based therapies alter dietary patterns by reducing cravings for high-fat and sugary foods, which may displace micronutrient-dense food groups if not actively managed.

You may naturally crave less junk food. Use this opportunity to fill your plate with vegetables and lean proteins to ensure you get enough vitamins and minerals.

GLP-1 receptor agonist use during radiation therapy causes rapid weight loss and anatomic changes that compromise immobilization reproducibility and dosimetric accuracy, necessitating adaptive radiotherapy or temporary holding of the medication.

If you are taking GLP-1 drugs (like Ozempic or Wegovy) while getting radiation, tell your radiation team immediately. These drugs cause weight loss and stomach changes that can make your radiation treatment less accurate. Your team may ask you to pause the drug or scan you more often to adjust the treatment plan. This is to keep you safe and ensure the radiation hits the tumor correctly.

Dose de-escalation (tapering) or low-dose maintenance therapy may modestly limit the rate and magnitude of weight regain compared to abrupt cessation, but robust randomized evidence is currently lacking.

If you want to stop your incretin medication, talk to your doctor about tapering the dose or extending the time between injections rather than stopping abruptly. While this might help slow down weight regain, it is not a guaranteed solution, and you should expect some regain. Continuing at a lower dose is generally better than stopping completely.

Nutrient-stimulated hormone (NuSH) therapies, including GLP-1 and dual/tri-agonists, produce significant weight loss and cardiometabolic improvements in real-world settings, though response heterogeneity, high discontinuation rates, and post-cessation weight regain remain unresolved challenges.

NuSH therapies (like semaglutide or tirzepatide) are highly effective for significant weight loss and metabolic health in real-world use, but they are not magic bullets. Expect a significant portion of people to not respond well, experience side effects leading to stopping the drug, or regain weight after stopping. Success requires individualized dosing, lifestyle support, and an understanding that obesity management is often a long-term commitment rather than a quick fix.

β-hydroxy-β-methylbutyrate (HMB, 3 g/day) has conditional utility for muscle hypertrophy, showing benefits primarily during high training stress or caloric deficits, but is largely neutral in well-fed, resistance-trained individuals.

If you are dieting or doing extremely high-volume training, 3g of HMB daily might help preserve muscle. If you are eating well and training normally, HMB is likely a waste of money as it shows no benefit in this group.

Adjunct supplements (omega-3 fatty acids, citrulline, collagen) facilitate training tolerance, recovery, or connective-tissue adaptation but do not directly drive muscle hypertrophy.

These supplements can help you train better, recover faster, or keep your tendons healthy, but they won't build muscle directly. Focus on protein, creatine, and training first; these are optional extras for specific needs.